A new USC study is adding to the evidence that so-called forever chemicals may carry serious long-term public health risks, after researchers linked two less-studied PFAS compounds to a higher risk of liver cancer.
The study, published in Environmental Health Perspectives, found that PFHpA and PFNA were associated with significantly higher odds of hepatocellular carcinoma, the most common form of liver cancer. The findings were strongest in people with a genetic predisposition to metabolic dysfunction-associated steatotic liver disease, also known as fatty liver disease.
Why these PFAS matter
PFAS are used in a wide range of everyday products, including nonstick cookware, food packaging, stain-resistant fabrics and firefighting foam. Because they break down very slowly, they can persist in the environment and in the human body for years or decades. The study notes that PFAS have been found in drinking water across roughly half of U.S. water systems, and that an estimated 99% of the world’s population has detectable levels of PFAS in their blood.
Researchers analyzed prediagnostic blood samples collected an average of 7.8 years before diagnosis from 223 people who later developed liver cancer and 223 matched controls. Of the 12 PFAS compounds measured, the two that stood out were PFHpA and PFNA. People in the highest quartile of exposure to either chemical had two to two-and-a-half times the odds of developing liver cancer compared with those in the lowest quartile.
Genetics may amplify the risk
The study is also notable because it examined how genetic susceptibility and chemical exposure may interact. Using a polygenic risk score for fatty liver disease, the researchers found that the PFHpA-liver cancer link was much stronger among people with high genetic susceptibility. Among those with low genetic susceptibility, there was no significant association.
According to the researchers, PFAS may interfere with the liver’s ability to metabolize fats, promoting fat accumulation that can progress to cancer over time. The study also said the strongest associations were not found in the most studied legacy PFAS, suggesting that attention should extend beyond the compounds that have already received the most regulatory scrutiny.
Hepatocellular carcinoma carries a five-year survival rate of less than 20%, and the study says MASLD is now the fastest-growing driver of the disease. That makes the findings especially relevant for prevention efforts, particularly if future research confirms the link between newer PFAS and liver cancer risk.
The researchers say their work adds to growing concern about the health impact of persistent environmental chemicals and underscores the need to better understand which PFAS are driving risk. The study was based on the Multiethnic Cohort Study, one of the few cohorts with pre-diagnostic blood samples collected long before disease developed.
Photo source: AI-generated or edited image



